Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Fisher Wallace Stimulator® has been FDA-cleared for the treatment of depression, anxiety, and insomnia. Over clinical use with more than 35,000 patients reported less than a one percent rate of minor side effects. Some independent clinicians report high efficacy rates in practice settings. However, systematic reviews have found insufficient evidence to definitively establish safety or efficacy compared to placebo. The company has invested in additional clinical trials during the pandemic and submitted results to the FDA.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fisher Wallace Laboratories.